Industry news

• Russia Donates Cholera Relief Supplies to Zimbabwe

  08 August 2024 GxP news

  Russia has donated cholera relief supplies to Zimbabwe to help combat the ongoing outbreak. The handover ceremony took place with representatives from both countries present, emphasizing the importance of international cooperation in addressing health crises.

• New Eco-Friendly Fertilizer Plant Constructed in Kaliningrad

  08 August 2024 GxP news

  The Kaliningrad Potash Company has inaugurated a new plant for producing environmentally friendly fertilizers with high concentrations of fulvic and humic acids in the Kaliningrad Region. The plant is the only producer of fulvates in Russia, which serve as natural plant growth stimulants. Production is carried out using German technology and is completely safe for the environment. Currently, the plant produces 200 tons of fertilizers per month, which corresponds to 2,000 tons per year.

• Circle of Kindness Foundation Starts Stockpiling Orphan Drugs

  07 August 2024 GxP news

  The state Circle of Kindness Foundation has begun forming a reserve of unregistered medicines in Russia to ensure uninterrupted treatment for children with orphan diseases, based on requests from regions and federal centers. The first drug procured is belumosudil, used to prevent chronic graft-versus-host disease. This batch will be sent to the R. M. Gorbacheva Research Institute and the N. N. Blokhin National Medical Research Center.

• Construction of New Manufacturing Complex by Active Component Begins in St. Petersburg

  07 August 2024 GxP news

  On July 30, St. Petersburg witnessed the groundbreaking ceremony for the new manufacturing complex of Active Component JSC. The event was attended by representatives from the Ministry of Industry and Trade, Ministry of Health, the St. Petersburg administration, and the pharmaceutical industry. Supported by the Ministry of Industry and Trade under the Cluster Investment Platform, this project aims to enhance import independence in the pharmaceutical sector.

• Paige publishes open-source AI pathology models for cancer R&D

  06 August 2024 Conor Hale / FiercePharma

  Earlier this year, Paige raised the curtain and spotlighted new artificial intelligence models for digital cancer pathology. Now, the company is offering a peek behind the curtain by making versions of two of its programs open-source.

• From biologics to small molecules – the shift in biopharma’s revenue growth

  06 August 2024 Catherine Eckford / European Pharmaceutical Review

  Biopharma companies that experienced strong revenue growth due to COVID-19 drug sales have been overtaken by companies that developed obesity drugs in 2023, GlobalData suggests.

• Utilising naturally occurring endotoxins in recovery studies

  05 August 2024 Catherine Eckford / European Pharmaceutical Review

  The research aimed to address concerns from regulatory agencies about accepting low endotoxin recovery studies that use a naturally occurring endotoxin analyte.

• Potential new antibiotic passes preclinical test against flesh-eating bacteria

  05 August 2024 Darren Incorvaia / FierceBiotech

  Flesh-eating bacteria sound like something an enterprising science fiction author would dream up, but they are, in fact, real—and the infections they cause can lead to disfigurement, loss of limbs and even death.

• In Altai, medicinal production rose by 102.5% and dietary supplements by 5.2%

  02 August 2024 GxP news

  The production index of food products, beverages, and medicines in the Altai Territory experienced a significant growth rate of 104.3% during the first half of 2024 (January-June). This achievement, compared to the same period of the previous year, is a testament to the dedicated efforts of the regional department for food, processing, pharmaceutical industry, and biotechnology, led by Alexander Bolshakov.

• Indian Pharmaceutical Companies Interested in Localizing Production in Russia

  02 August 2024 GxP news

  Indian pharmaceutical companies are keen to localize their drug production in Russia, seeking joint ventures in the sector. This trend of establishing manufacturing bases in partner countries is seen as natural by both Indian and Russian firms, according to Mir Faruk, Vice President of the Indian Business Council and head of Ipca Laboratories’ Russian office.